miRNA gene therapy (Beijing SoloBio Gene Technology)

N/A

Report date: 2025/01/26 15:50:05
NME

Base Information

Drug NamemiRNA gene therapy (Beijing SoloBio Gene Technology)
Drug Alias NamemiRNA gene therapy (Staidson (Beijing) Biopharmaceutical)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Solarbio Science & Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Solarbio Science & Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A